How Many Lymph Nodes are Enough in Thyroidectomy? A Cohort Study Based on Real-World Data

被引:1
|
作者
Wei, Bo [1 ]
Tan, Hai-Long [1 ]
Chen, Lu [1 ]
Chang, Shi [1 ,2 ,3 ,4 ,5 ,6 ]
Wang, Wen-long [7 ,8 ]
机构
[1] Cent South Univ, Xiangya Hosp, Gen Surg Dept, Div Thyroid Surg, Changsha, Hunan, Peoples R China
[2] Hunan Prov Clin Med Res Ctr Thyroid Dis, Changsha, Hunan, Peoples R China
[3] Hunan Engn Res Ctr Thyroid & Related Dis Diag & Tr, Changsha, Hunan, Peoples R China
[4] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Hunan, Peoples R China
[5] Furong Lab, Changsha, Hunan, Peoples R China
[6] Natl Engn Res Ctr Personalized Diagnost & Therapeu, Changsha, Hunan, Peoples R China
[7] Cent South Univ, Xiangya Hosp, Dept Breast Surg, Changsha, Hunan, Peoples R China
[8] Clin Res Ctr Breast Canc Hunan Prov, Changsha, Hunan, Peoples R China
关键词
Papillary thyroid cancer; Examined lymph node; Occult nodal disease; Lymph node dissection; Recurrence-free survival; LATERAL NECK; ASSOCIATION GUIDELINES; CANCER; METASTASIS; YIELD; RISK; MANAGEMENT; DISSECTION; RECURRENCE; CARCINOMA;
D O I
10.1245/s10434-024-16391-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThyroidectomy with only limited examination of lymph nodes is considered to pose potential risk for harboring occult nodal disease in patients with papillary thyroid cancer (PTC). However, the optimal number of examined lymph nodes (ELNs) in patients with PTC with clinically lateral lymph node metastasis (cN1b) remains unclear.Patients and MethodsPatients with cN1b PTC who underwent therapeutic neck dissection were retrospectively enrolled. A beta-binomial distribution was utilized to calculate the likelihood of occult nodal disease as a function of total number of ELNs, and recurrence-free survival analysis was performed using the Kaplan-Meier method.ResultsTogether 982 patients met the inclusion criteria for this study, of which 853 patients had node-positive disease. The median ELN count was 23 (interquartile range 14-33). Increased ELN counts were associated with a decreased rate of occult nodal disease. The prevalence of nodal metastasis was 84%, while the corrected prevalence was 90%. The estimated probability of false-negative nodal disease was 67% for patients with PTC when only a single node was examined. Survival analysis revealed that populations with higher probability of occult nodal diseases experienced significantly higher recurrence rate. For patient with cN1b PTC, 20 ELNs were required to achieve 95% confidence of having no occult nodal disease. Minimum thresholds of 24, 14, 14, and 15 ELNs were selected for patients with pT1, pT2, pT3, and pT4 diseases, respectively.ConclusionsOur findings robustly conclude that a minimum of 20 ELNs is essential to assess the quality of neck dissection and acquire accurate staging for patients with cN1b PTC.
引用
收藏
页码:1149 / 1157
页数:9
相关论文
共 50 条
  • [41] Real-World Outcomes of Systemic Therapy in Japanese Patients with Cancer (Tokushukai REAl-World Data Project: TREAD): Study Protocol for a Nationwide Cohort Study
    Shimoyama, Rai
    Imamura, Yoshinori
    Uryu, Kiyoaki
    Mase, Takahiro
    Fujimura, Yoshiaki
    Hayashi, Maki
    Ohtaki, Megu
    Ohtani, Keiko
    Shinozaki, Nobuaki
    Minami, Hironobu
    HEALTHCARE, 2022, 10 (11)
  • [42] Defining Optimal Lymph Node Yield in Gastrectomy: A Real-World Cohort Analysis
    Rui Li
    Xu Sun
    Zhiyuan Yu
    Xiangchao Zhu
    Xudong Zhao
    Peiyu Li
    Na Liu
    World Journal of Surgical Oncology, 23 (1)
  • [43] A real-world study of Alemtuzumab in a cohort of Italian patients
    Sacca, F.
    Russo, C. V.
    Frau, J.
    Annovazzi, P.
    Signoriello, E.
    Bonavita, S.
    Grasso, R.
    Clerico, M.
    Cordioli, C.
    Laroni, A.
    Capobianco, M.
    Clerici, V. Torri
    Sartori, A.
    Cavalla, P.
    Maniscalco, G. T.
    La Gioia, S.
    Caleri, F.
    Giugno, A.
    Iodice, R.
    Carotenuto, A.
    Cocco, E.
    Fenu, G.
    Zaffaroni, M.
    Baronicini, D.
    Lus, G.
    Gallo, A.
    De Mercanti, S. F.
    Lapucci, C.
    Di Francescantonio, V.
    Sormani, M. P.
    Signori, A.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 796 - 797
  • [44] Emicizumab treatment and monitoring in a paediatric cohort: real-world data
    Barg, Assaf A.
    Livnat, Tami
    Budnik, Ivan
    Avishai, Einat
    Brutman-Barazani, Tami
    Tamarin, Ilia
    Bashari, Dalia
    Misgav, Mudi
    Kenet, Gili
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 191 (02) : 282 - 290
  • [45] A real-world study of alemtuzumab in a cohort of Italian patients
    Russo, Cinzia Valeria
    Sacca, Francesco
    Frau, Jessica
    Annovazzi, Pietro
    Signoriello, Elisabetta
    Bonavita, Simona
    Grasso, Roberta
    Clerico, Marinella
    Cordioli, Cinzia
    Laroni, Alice
    Capobianco, Marco
    Clerici, Valentina Torri
    Sartori, Arianna
    Cavalla, Paola
    Maniscalco, Giorgia Teresa
    La Gioia, Sara
    Caleri, Francesca
    Giugno, Alessia
    Iodice, Rosa
    Carotenuto, Antonio
    Cocco, Eleonora
    Fenu, Giuseppe
    Zaffaroni, Mauro
    Baroncini, Damiano
    Lus, Giacomo
    Gallo, Antonio
    De Mercanti, Stefania Federica
    Lapucci, Caterina
    Di Francescantonio, Valeria
    Brambilla, Laura
    Sormani, Maria Pia
    Signori, Alessio
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (01) : 257 - 266
  • [46] The influence of constipation on asthma: A real-world, population-based cohort study
    Huang, Yen-Chu
    Wu, Meng-Che
    Wang, Yu-Hsun
    Wei, James Cheng-Chung
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021,
  • [47] Cefto Real-Life Study: Real-World Data on the Use of Ceftobiprole in a Multicenter Spanish Cohort
    Hidalgo-Tenorio, Carmen
    Pitto-Robles, Ines
    Garcia, Daniel Arnes
    de Novales, F. Javier Membrillo
    Morata, Laura
    Mendez, Raul
    de Pablo, Olga Bravo
    de Medrano, Vicente Abril Lopez
    Lleti, Miguel Salavert
    Vizcarra, Pilar
    Lora-Tamayo, Jaime
    Garcia, Ana Arnaiz
    Nunez, Leonor Moreno
    Masia, Mar
    Seco, Maria Pilar Ruiz
    Sadyrbaeva-Dolgova, Svetlana
    ANTIBIOTICS-BASEL, 2023, 12 (07):
  • [48] Real-World Use and Outcomes of Olaparib: a Population-Based Cohort Study
    Eriksson, Irene
    Wettermark, Bjorn
    Bergfeldt, Kjell
    TARGETED ONCOLOGY, 2018, 13 (06) : 725 - 733
  • [49] Real-World Use and Outcomes of Olaparib: a Population-Based Cohort Study
    Irene Eriksson
    Björn Wettermark
    Kjell Bergfeldt
    Targeted Oncology, 2018, 13 : 725 - 733
  • [50] Battery Identification Based on Real-World Data
    Zhang, Miao
    Miao, Zhixin
    Fan, Lingling
    2017 NORTH AMERICAN POWER SYMPOSIUM (NAPS), 2017,